RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) (ALLSTAR)
A Randomized Controlled Trial of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)
Sponsor: Abramson Cancer Center at Penn Medicine
A NA clinical study on Breast Cancer and Cardiovascular Diseases, this trial is completed. The trial is conducted by Abramson Cancer Center at Penn Medicine and has accumulated 13 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Mar 2025 — Sep 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 8 earlier versions
-
May 2024 — Jun 2024 [monthly]
Recruiting NA
-
Dec 2023 — May 2024 [monthly]
Recruiting NA
-
Jun 2023 — Dec 2023 [monthly]
Recruiting NA
-
Apr 2023 — Jun 2023 [monthly]
Recruiting NA
-
Mar 2023 — Apr 2023 [monthly]
Recruiting NA
-
Sep 2022 — Mar 2023 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2022 — Jun 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
- American Heart Association
- City of Hope National Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .